N/A
N=270
The Digital Wellbeing Project
Mental Health
Bottom Line
View on ClinicalTrials.gov: NCT05061966 ↗Enrolled (actual)
270
Serious AEs
0.0%
Results posted
Jun 2023
Primary outcome: Primary: Coping Self-efficacy — 3.32; 3.64; 3.92; 3.85 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- immi (Behavioral); Control (Behavioral)
- Age
- Pediatric, Adult · 13+ yrs
- Sex
- All
- Sponsor
- University of Pennsylvania
- Primary completion
- Dec 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Coping Self-efficacy |
3.32; 3.64; 3.92; 3.85; 3.67; 3.83 | — |
| SECONDARY Identity Affirmation |
5.08; 5.10 | — |
| SECONDARY Internalization of Minority Stress |
2.94; 3.19 | — |
| SECONDARY Sense of Belonging to the Queer Community |
18.21; 17.15 | — |
| SECONDARY Anxiety Symptoms |
10.30; 9.92 | — |
| SECONDARY Depression Symptoms |
11.40; 11.61 | — |
| SECONDARY Cognitive and Behavioral Coping Skills |
3.23; 3.23; 2.47; 2.65; 2.43; 2.59 | — |
Summary
This goal of this randomized control trial is to test whether a web application that provides sexual and gender minority youth ages 13-19 (N=200) with tools for affirming their identities and coping with minority stress can affect key psychosocial outcomes, such as coping self-efficacy and symptoms of anxiety and depression.
Eligibility Criteria
Inclusion Criteria
- Are between 13-19 years of age (inclusive)
- Self-identify as a sexual or gender minority
- Are English literate
- Reside within the United States
- Have access to a device that has internet access, a web browser, and SMS capabilities, such as a smartphone, computer, or tablet
- Willingness to participate in study activities
Exclusion Criteria
- Not between 13-19 years of age (inclusive)
- Does not self-identify as a sexual or gender minority
- Is not English literate
- Does not reside within the United States
- Does not have access to a device that has internet access, a web browser, and SMS capabilities, such as a smartphone, computer, or tablet
- Unwilling to participate in study activities
Data sourced from ClinicalTrials.gov (NCT05061966). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.